|
Did you know that miniature swine is often a viable option for your nonclinical program?
Presented by Altasciences’s Senior Vice President of Research, Scott E. Boley, Ph.D, DABT, and Sinclair BioResources' Derek Brocksmith, this complimentary webinar discusses the scientific rationale for using the miniature swine as a second species for your IND programs. In addition, we describe the different miniature swine strains which may affect your species selection process.
Topics covered include:
- The selection criteria for miniature swine models
- The use of miniature swine as a second species for different molecule types
- Comparative pharmacological data of several different miniature swine models
- Special considerations for toxicology and pharmacology study parameters
Watch the Webinar
Speak with an expert to learn more about the possibility of using the miniature swine for your upcoming nonclinical drug development program.
Refer to these two guidance documents which can help with your species selection:
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services.
|